(Re)writing the Future
Memorial Sloan Kettering Cancer Center and Hackensack Meridian Health announced the Memorial Sloan Kettering–Hackensack Meridian Health partnership, which brings together two world-class organizations with deep New Jersey roots and a single goal: Finding more cures for cancer faster while ensuring that patients have access to the highest-quality, most individualized cancer care when and where they need it.
Unparalleled expertise in cancer care and research
To achieve this goal, the new Memorial Sloan Kettering–Hackensack Meridian Health partnership will combine both organizations’ unparalleled expertise in all areas of cancer care and research, as well as their commitment to excellence, to accelerate new discoveries and improve the lives of patients they jointly serve, while training a new generation of leaders in the field.
Driving the collaboration is a shared commitment to the highest-quality cancer care and improving outcomes and value.
This will allow the two organizations to reduce the burden that cancer places on patients and families. The partnership also supports Vice President Joe Biden’s National Cancer Moonshot initiative, which calls for unprecedented cooperation among leading cancer centers to make more therapies available to more patients, while also improving the ability to prevent cancer and detect it at an early stage.
Creating greater access to care
The Memorial Sloan Kettering–Hackensack Meridian Health partnership aims to improve the state of cancer care in New Jersey and beyond by providing support to patients throughout the cancer care continuum, from diagnosis through active treatment and into survivorship. More New Jersey communities than ever will have access to hundreds of clinical trials for many cancer types, including the phase I trials that both Memorial Sloan Kettering and Hackensack Meridian Health offer.